BPH procedures relieve urinary obstruction by removing, separating, shrinking or reducing the blood supply to enlarged prostate tissue. TURP, HoLEP, UroLift, Rezūm, Aquablation and prostate artery embolization use very different techniques, so recovery, durability, bleeding risk and effects on ejaculation are not the same.
01. BPH Surgery: Indications, Technique and Treatment Role
What problems are BPH procedures intended to treat?
BPH procedures are primarily used to relieve benign prostatic obstruction when enlarged prostate tissue restricts urine flow through the prostatic urethra.
A procedure may be considered when urinary symptoms remain significantly bothersome despite conservative care or medication, or when obstruction produces complications.
Current European guidance identifies several situations in which surgical treatment becomes particularly important, including:
- recurrent or persistent urinary retention;
- overflow incontinence related to poor emptying;
- recurrent urinary tract infections;
- bladder stones or significant bladder diverticula;
- persistent visible blood in the urine attributed to BPH despite treatment;
- upper urinary tract dilation caused by obstruction;
- renal impairment related to bladder-outlet obstruction;
- or persistent troublesome symptoms despite appropriate medical treatment.
What happens before and during a BPH procedure?
Before selecting a procedure, clinicians review the urinary symptoms, medical conditions, medicines and previous treatments. Evaluation commonly includes examination of the prostate and assessment of urinary flow and bladder emptying.
Prostate size and anatomy are especially important because different procedures work better in different anatomical situations. Median-lobe enlargement, intravesical prostate protrusion, urethral disease, bladder abnormalities and very large prostate volume can change the treatment plan.
Depending on the patient and procedure, assessment may include prostate imaging, uroflowmetry, post-void residual measurement, urinalysis, PSA testing when relevant and cystoscopy when direct visualization of the urethra or bladder is needed.
Most surgical BPH procedures reach the prostate through the urethra. Prostate artery embolization is different because it reaches the prostate through blood vessels rather than through the urinary tract.
02. How Are BPH Surgery and Minimally Invasive Procedures Performed?
How do TURP, HoLEP, UroLift, Rezūm, Aquablation and PAE differ?
| Procedure | How it relieves obstruction | Typical clinical role | Important trade-off |
|---|---|---|---|
| TURP | Electrosurgical instruments remove obstructing prostate tissue through the urethra. | Established surgical treatment, particularly for moderate-sized prostates. | Strong symptom and flow improvement, but bleeding, urethral complications and ejaculatory dysfunction can occur. |
| HoLEP | A holmium laser separates enlarged adenoma from the prostate capsule so tissue can be removed. | Effective across a wide range of prostate sizes, including large glands. | Durable and relatively favorable for bleeding, but requires specialized equipment and surgical expertise. |
| UroLift | Small implants retract prostate tissue away from the urethra without removing it. | Selected men prioritizing faster recovery and preservation of ejaculation. | Less improvement in flow than tissue-removing surgery and a higher likelihood of later retreatment. |
| Rezūm | Water vapor delivers thermal energy that causes selected prostate tissue to shrink over time. | Minimally invasive treatment that may be performed in an outpatient or office-based setting. | Recovery can involve temporary urinary irritation or catheterization; comparative long-term evidence is less extensive than for established surgery. |
| Aquablation | An image-guided robotic system directs a high-velocity saline waterjet to remove prostate tissue without thermal cutting. | Alternative to TURP in appropriately selected men, including those prioritizing ejaculatory preservation. | Requires operating-room technology and active management of procedural bleeding. |
| Prostate artery embolization | An interventional radiologist blocks selected prostate arteries, reducing blood supply so the gland gradually shrinks. | Selected men seeking a less invasive vascular treatment and willing to accept different efficacy and durability trade-offs. | Objective urinary improvement is generally less than TURP and later retreatment is more common. |
Which anatomy, prostate size or disease factors affect procedure selection?
Prostate size is one of the major treatment variables, but it is not the only one.
Current EAU guidance describes TURP as a standard surgical procedure for men with moderate-to-severe symptoms from benign prostatic obstruction and prostate volumes of approximately 30–80 mL.
HoLEP can be used across a broader range of gland sizes and is frequently considered when the prostate is large. Outcomes also depend strongly on surgeon experience.
For UroLift, European guidance favors men interested in preserving ejaculation who have prostates below approximately 70 mL without an obstructing middle lobe.
Aquablation has strong evidence as an alternative to TURP in prostates around 30–80 mL, with additional evidence supporting use in selected larger glands. Preservation of antegrade ejaculation is one potential advantage.
Rezūm can treat lateral-lobe tissue and may also be applied to selected median-lobe enlargement. Its less invasive nature and sexual-function preservation are important advantages for some men, although comparative evidence against established surgical techniques is less mature.
PAE depends not only on prostate anatomy but also on pelvic arterial anatomy and access. European guidance recommends that patient selection and follow-up involve collaboration between urologists and appropriately trained interventional radiologists.
Other BPH procedures also exist. Depending on anatomy and patient factors, treatment may include GreenLight laser photoselective vaporization or simple prostatectomy for selected very large glands.
03. BPH Surgery: Outcomes, Recovery and Procedure-Specific Trade-Offs
What does recovery after BPH treatment usually involve?
Recovery differs substantially because these procedures range from office-based treatments to operating-room surgery.
TURP, HoLEP and Aquablation are generally performed under anesthesia and often require temporary urinary catheterization. Hospital stay varies according to the procedure, bleeding, patient health and local practice.
UroLift and Rezūm are often performed as outpatient procedures. Burning with urination, frequency, urgency, pelvic discomfort or mild blood in the urine can occur temporarily after treatment. Some men require a catheter while swelling settles.
PAE is usually performed through an artery in the wrist or groin using local anesthesia and image guidance. It can often be performed as a day procedure.
Symptom improvement also occurs at different speeds. Tissue-removing procedures such as TURP and HoLEP can provide relatively rapid improvement after postoperative swelling resolves. Rezūm and PAE depend partly on tissue shrinking over time, so improvement is more gradual.
Which urinary or sexual effects should be discussed before a procedure?
BPH procedures can substantially improve urinary flow and symptom burden, but treatment can also produce adverse effects.
Important urinary risks can include:
- temporary urinary retention;
- urinary tract infection;
- bleeding or blood in the urine;
- temporary urgency or frequency;
- urethral stricture;
- bladder-neck narrowing;
- temporary or persistent urinary incontinence in a minority of patients;
- and the possibility of needing another BPH procedure later.
Sexual effects differ substantially between procedures.
TURP and conventional HoLEP frequently alter ejaculation because removal of tissue around the bladder outlet changes the normal pathway of semen during orgasm. Erectile function is usually a separate issue and should not be assumed to change in the same way as ejaculation.
UroLift is specifically used in selected men who place a high priority on preserving ejaculatory function. Rezūm also has a relatively favorable sexual-function profile in published studies.
Aquablation has shown relatively high preservation of antegrade ejaculation compared with traditional resection in appropriately selected men.
PAE generally avoids direct instrumentation or removal of prostate tissue, but sexual and urinary outcomes still need to be considered alongside its lower objective efficacy and higher retreatment likelihood compared with TURP.
For broader information about erections, see Erectile Dysfunction .
04. Who Is Most Likely to Be Considered for BPH Surgery?
How do BPH procedures compare with medication and with each other?
Medication is often tried before a procedure when symptoms are uncomplicated and the bladder and kidneys are not threatened.
Alpha blockers can provide relatively rapid symptom relief but do not remove the obstruction or reduce long-term progression risk. Finasteride and dutasteride can shrink enlarged prostates and reduce progression risk but usually require months to produce their full effect.
A procedure becomes more relevant when medication provides insufficient relief, causes unacceptable adverse effects, the patient prefers a more definitive approach or BPH has produced complications.
| Priority | Procedure characteristics that may matter |
|---|---|
| Strong established flow improvement | TURP, HoLEP and other tissue-removing or enucleating procedures generally provide substantial decompression. |
| Very large prostate | HoLEP and selected enucleation or simple prostatectomy techniques can be particularly relevant. |
| Preserving ejaculation | UroLift and Aquablation may be attractive in appropriately selected anatomy; Rezūm also has a relatively favorable sexual profile. |
| Faster outpatient recovery | UroLift, Rezūm and PAE may reduce some aspects of postoperative recovery compared with conventional tissue-removing surgery. |
| Avoiding transurethral prostate surgery | PAE approaches the prostate through its arterial supply rather than the urethra. |
| Long-term durability | Established tissue-removing procedures such as TURP and HoLEP generally have stronger long-term durability evidence than some minimally invasive alternatives. |
When is a BPH procedure unsuitable or followed by additional evaluation?
A procedure should not be selected solely because urinary symptoms are present. Lower urinary tract symptoms can also result from bladder dysfunction, urethral narrowing, neurological disease, infection, medication effects or other urinary conditions.
Further evaluation may be needed when symptoms and objective findings do not fit together, when bladder contraction appears weak, when unexplained hematuria is present or when cancer, urethral disease or bladder pathology needs separate assessment.
A man with severe detrusor underactivity may not experience the same improvement after outlet surgery as a man whose main problem is mechanical obstruction. In selected uncertain cases, urodynamic testing may help separate bladder-outlet obstruction from impaired bladder contractility.
The goal is therefore not simply to choose a surgical technology. It is to identify the mechanism causing the urinary problem and select a treatment capable of changing that mechanism.
Summary
- BPH procedures are considered when obstruction causes persistent symptoms, complications or inadequate response to conservative or medical treatment.
- TURP removes obstructing tissue and remains an established surgical standard for many moderate-sized prostates.
- HoLEP enucleates prostate adenoma with a laser and is effective across a broad range of prostate sizes.
- UroLift opens the urethra with implants and can better preserve ejaculation, but retreatment is more common than after TURP.
- Rezūm uses water vapor to shrink targeted prostate tissue and generally preserves sexual function.
- Aquablation uses image-guided waterjet ablation and combines substantial urinary improvement with relatively favorable ejaculatory preservation.
- PAE reduces prostate blood supply without entering the urinary tract, but urinary improvement is generally less than TURP and retreatment is more frequent.
- No procedure is universally best; anatomy, prostate size, obstruction severity, recovery priorities, sexual function and durability must be considered together.
Educational disclaimer: This article provides general medical education and does not recommend a particular BPH procedure for an individual. Procedure selection requires evaluation by a qualified urology or other appropriately trained specialist.
Evidence Sources
- European Association of Urology. 2026 Guidelines on the Management of Non-neurogenic Male LUTS: Disease Management.
- European Association of Urology. 2026 Guidelines on Non-neurogenic Male Lower Urinary Tract Symptoms.
- National Institute of Diabetes and Digestive and Kidney Diseases. Enlarged Prostate (Benign Prostatic Hyperplasia).
